These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25393628)
1. Liposomes modified with superhydrophilic polymer linked to a nonphospholipid anchor exhibit reduced complement activation and enhanced circulation. Nag OK; Yadav VR; Croft B; Hedrick A; Awasthi V J Pharm Sci; 2015 Jan; 104(1):114-23. PubMed ID: 25393628 [TBL] [Abstract][Full Text] [Related]
2. Anchoring Property of a Novel Hydrophilic Lipopolymer, HDAS-SHP, Post-Inserted in Preformed Liposomes. Mare R; Da H; Fresta M; Cosco D; Awasthi V Nanomaterials (Basel); 2019 Aug; 9(9):. PubMed ID: 31438526 [TBL] [Abstract][Full Text] [Related]
3. Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo. Nag OK; Yadav VR; Hedrick A; Awasthi V Int J Pharm; 2013 Mar; 446(1-2):119-29. PubMed ID: 23419666 [TBL] [Abstract][Full Text] [Related]
4. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
5. A novel liposome surface modification agent that prolongs blood circulation and retains surface ligand reactivity. Ishihara A; Yamauchi M; Tsuchiya T; Mimura Y; Tomoda Y; Katagiri A; Kamiya M; Nemoto H; Suzawa T; Yamasaki M J Biomater Sci Polym Ed; 2012; 23(16):2055-68. PubMed ID: 22054261 [TBL] [Abstract][Full Text] [Related]
6. Enhanced circulation time and antitumor activity of doxorubicin by comblike polymer-incorporated liposomes. Han HD; Lee A; Hwang T; Song CK; Seong H; Hyun J; Shin BC J Control Release; 2007 Jul; 120(3):161-8. PubMed ID: 17524514 [TBL] [Abstract][Full Text] [Related]
7. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy. Pasut G; Paolino D; Celia C; Mero A; Joseph AS; Wolfram J; Cosco D; Schiavon O; Shen H; Fresta M J Control Release; 2015 Feb; 199():106-13. PubMed ID: 25499917 [TBL] [Abstract][Full Text] [Related]
8. Superhydrophilic zwitterionic polymers stabilize liposomes. Cao Z; Zhang L; Jiang S Langmuir; 2012 Aug; 28(31):11625-32. PubMed ID: 22783927 [TBL] [Abstract][Full Text] [Related]
9. Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. Cai D; Gao W; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2014 Feb; 35(7):2283-94. PubMed ID: 24360410 [TBL] [Abstract][Full Text] [Related]
10. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. Ishida T; Atobe K; Wang X; Kiwada H J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355 [TBL] [Abstract][Full Text] [Related]
11. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. Laverman P; Carstens MG; Boerman OC; Dams ET; Oyen WJ; van Rooijen N; Corstens FH; Storm G J Pharmacol Exp Ther; 2001 Aug; 298(2):607-12. PubMed ID: 11454922 [TBL] [Abstract][Full Text] [Related]
12. Two cholesterol derivative-based PEGylated liposomes as drug delivery system, study on pharmacokinetics and drug delivery to retina. Geng S; Yang B; Wang G; Qin G; Wada S; Wang JY Nanotechnology; 2014 Jul; 25(27):275103. PubMed ID: 24960297 [TBL] [Abstract][Full Text] [Related]
13. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations. Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464 [TBL] [Abstract][Full Text] [Related]
14. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo. Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695 [TBL] [Abstract][Full Text] [Related]
15. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity. Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094 [TBL] [Abstract][Full Text] [Related]
16. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery. Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866 [TBL] [Abstract][Full Text] [Related]
17. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702 [TBL] [Abstract][Full Text] [Related]
18. Biological evaluation of liposome-encapsulated hemoglobin surface-modified with a novel PEGylated nonphospholipid amphiphile. Yadav VR; Nag O; Awasthi V Artif Organs; 2014 Aug; 38(8):625-33. PubMed ID: 24749870 [TBL] [Abstract][Full Text] [Related]
19. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782 [TBL] [Abstract][Full Text] [Related]